Anti-inflammatory Therapeutics Market

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Anti-inflammatory Therapeutics Market aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapeutics. Anti-inflammatory Therapeutics Market contains market size and forecasts of Anti-inflammatory Therapeutics in global, including the following market information:
Global Anti-inflammatory Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anti-inflammatory Therapeutics market was valued at US$ 113740 million in 2022 and is projected to reach US$ 169200 million by 2029, at a CAGR of 5.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
We surveyed the Anti-inflammatory Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• Anti-inflammatory Biologics
• Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
• Corticosteroids
• Others

• Arthritis
• Respiratory Diseases
• Dermatology
• Gastroenterology
• Others

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Anti-inflammatory Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Anti-inflammatory Therapeutics revenues share in global market, 2022 (%)

• AbbVie
• Johnson & Johnson
• Amgen Inc
• AstraZeneca PLC
• Pfizer, Inc
• Novartis
• Roche
• Merck
• Sanofi
• GlaxoSmithKline
• Sun Pharmaceutical Industries Ltd
• TEVA

• Chapter 1: Introduces the definition of Anti-inflammatory Therapeutics, market overview.
• Chapter 2: Global Anti-inflammatory Therapeutics market size in revenue.
• Chapter 3: Detailed analysis of Anti-inflammatory Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Anti-inflammatory Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: The main points and conclusions of the report.